148 related articles for article (PubMed ID: 33468774)
1. [Breast Cancer with Cancerous Ascites with Good QOL by KM-CART-A Case Report].
Iimori N; Nishimura S; Kushitani Y; Tokumoto M; Taenaka N; Terashima K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1983-1985. PubMed ID: 33468774
[TBL] [Abstract][Full Text] [Related]
2. [Cell-Free Ascites Reinfusion Therapy(CART)Modified by Keisuke Matsusaki(KM-CART)at Our Hospital].
Iwaki R; Shindo K; Kawahara H; Nanba N; Kuramoto Y; Beppu T; Uesugi T; Tanaka Y; Uesugi Y
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2165-2167. PubMed ID: 30692319
[TBL] [Abstract][Full Text] [Related]
3. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
[TBL] [Abstract][Full Text] [Related]
5. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
Yamamoto K; Nagao S; Tsu T; Matsushima T; Ishido Y; Narita M; Suzuki K; Nakazawa H; Shibutani T; Jimi T; Yano H; Kitai M; Shiozaki T; Matsuoka K; Yamaguchi S
J Obstet Gynaecol Res; 2021 Apr; 47(4):1536-1543. PubMed ID: 33469981
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
[TBL] [Abstract][Full Text] [Related]
8. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
Yoshizawa M; Nakatsuji Y
Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Unresectable Pancreatic Cancer with Massive Cancerous Ascites Responsive to KM-CART].
Shirakawa K; Hirahara S; Kubota H; Kuhara Y; Toyota K; Yano R; Kobayashi H; Hashimoto Y; Yokoyama Y; Sakashita Y; Miyamoto K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):81-83. PubMed ID: 33468729
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Effective Peritoneo-Venous Shunt for Refractory Malignant Ascites in a Gastric Cancer Patient with Peritoneal Dissemination].
Sugamoto Y; Arasawa T; Fukunaga T; Tasaki K; Kuboshima M; Muto Y; Sazuka T; Kimura M; Asai Y; Fujita E; Ota T; Matsubara H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2059-2061. PubMed ID: 33468800
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.
Kawata Y; Nagasaka K; Matsumoto Y; Oda K; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Arimoto T; Osuga Y; Fujii T
Int J Clin Oncol; 2019 Apr; 24(4):420-427. PubMed ID: 30474762
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis.
Togami S; Hori S; Kamio M; Matsuo T; Yoshinaga M; Douchi T
Eur J Gynaecol Oncol; 2014; 35(3):301-3. PubMed ID: 24984546
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
Tsubokura M; Adegawa Y; Kojima M; Tanosaki R; Ohtake R; Kase Y; Iwashita N; Kasane M; Nakabayashi S; Takeuchi S; Kato K; Boku N; Kanemitsu Y; Okusaka T; Fujimoto H; Yonemori K; Ishiki H; Kawamura K; Satomi E; Matsushita H
BMC Cancer; 2022 Mar; 22(1):268. PubMed ID: 35287609
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
[TBL] [Abstract][Full Text] [Related]
16. [Two Cases of Peritoneal Dissemination of Gastric Cancer Treated with CART Followed by Chemotherapy].
Kitagawa Y; Katsuno A; Tamura N; Harada T; Abe S; Hamasaki S; Machida T; Nakanishi A; Ami K; Umetani N
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1887-1889. PubMed ID: 33468862
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
[TBL] [Abstract][Full Text] [Related]
18. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
19. Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation.
Takahashi H; Sakai R; Fujita A; Kuwabara H; Hattori Y; Matsuura S; Ohshima R; Hagihara M; Tomita N; Ishigatsubo Y; Fujisawa S
Artif Organs; 2013 Oct; 37(10):932-6. PubMed ID: 23692354
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of fever in cell-free and concentrated ascites reinfusion therapy is not related to the primary disease or nature of ascites.
Fukunaga S; Egawa M; Ito T; Tanabe K
J Artif Organs; 2024 Jun; 27(2):138-145. PubMed ID: 37178240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
